Editorial Policy
Effective June 4, 2026
Aminoscope is an independent research desk covering peptides, GLP-1 medications, and longevity therapeutics. This policy describes how we research a topic, where our facts come from, how we verify them, and how we keep commercial relationships out of our editorial judgments. It is the working contract behind every page we publish, and it complements our methodology, our code of conduct, and our disclosures.
1. Primary Sources Only
Every factual claim we make is tied to a primary source — the trial publication, the FDA or DailyMed label, the regulatory filing, or the peer-reviewed paper of record. We do not treat press releases, marketing pages, secondary blogs, or AI-generated summaries as evidence. When the strongest available evidence is preclinical, observational, or thin, we say so plainly rather than dressing it up as more than it is. We report effect sizes, hazard ratios, confidence intervals, and durations — magnitude, not adjectives.
2. Live Citation Verification
Citations are never reconstructed from memory. Before a piece is published, each reference is checked live against the source of record — PubMed, DailyMed, ClinicalTrials.gov, or the journal itself — to confirm the authors, the year, the journal, and the specific figure being cited. In practice we hold ourselves to a deliberately strict standard: we verify more citations than the bare minimum a claim requires, so that every load-bearing statement is over-sourced rather than under-sourced. A citation that cannot be located and confirmed in a primary database does not get published.
3. Editorial Independence — The Firewall
Aminoscope is reader-supported and earns revenue through clearly labeled affiliate partnerships, managed primarily through the Katalys network. Those relationships are walled off from our editorial judgment. A commercial relationship can affect display order — which partners are surfaced first, featured, or labeled as partners — but it never affects a verdict, a ranking rationale, a score, or a safety statement. A provider with an affiliate relationship is held to exactly the same evidence bar as one without, and a provider that performs poorly is described accordingly regardless of any commercial arrangement. For the full revenue picture and our FTC disclosure under 16 CFR Part 255, see our Disclosures; for how reviews are assessed, see Nature of Reviews.
4. Disclosed Pen Names
Our writers publish under consistent, disclosed pen names — a common and accepted practice in health and science journalism — so that the work is judged on its sourcing rather than on personality. These are stated to be pen names; we do not present them as claims of a specific named individual's real-world identity or credentials. Bylines are stable: the same name always reflects the same writer and beat. You can see the masthead on our authors page.
5. Medical-Review Status
We want to be honest about our review process rather than overstate it. Every page that discusses a medication or intervention is reviewed against primary sources before publication. At this time, Aminoscope does not have a licensed clinician on staff as a named medical reviewer. We do not claim individualized clinical review, and we do not present our content as clinician-authored care guidance. As the desk grows, adding a credentialed medical reviewer is a priority; until then, our standard is rigorous primary-source verification, plainly disclosed. This is also why a medical disclaimer appears on our health content.
6. AI-Assistance Transparency
Where drafting tools — including AI assistance — are used to help organize or draft material, the output is treated as a draft only. Every claim is then verified by a human against the primary literature using the live-verification process above, and the editorial responsibility for accuracy rests entirely with us. We do not publish unverified machine-generated claims, and AI summaries are never used as a source of fact.
7. Corrections
We correct errors promptly and visibly. If you find a misread figure, an outdated citation, or a broken source link, please tell us — see our corrections policy for how we log and date changes, or write to editorial@aminoscope.com.